查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1136902

全球診斷導管市場-2022-2029

Global Diagnostic Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球診斷導管市場的增長受到全球心血管手術數量不斷增加、外科手術以及微創手術趨勢等因素的推動。

不斷湧現的新穎和創新技術進步正在推動市場增長。

與診斷導管相關的技術進步正在推動全球市場增長。例如，2021 年 6 月，雅培宣布它可以支持對機械循環支持設備不斷增長的需求，以充分治療晚期心力衰竭。

根據國家健康和營養檢查調查 (NHANES) 數據 (2020)，估計有 620 萬美國 20 歲及以上成年人 (2.2%) 患有心力衰竭。超過 570 萬美國人患有心力衰竭，每年診斷出大約 915,000 例新病例。由於不健康的生活方式和環境變化，心力衰竭、心血管疾病和冠狀動脈疾病等慢性疾病的患病率在全球範圍內不斷增加。這些最新的產品發布和技術進步將能夠對抗這些疾病。例如，2022 年 4 月，富蘭克林醫療山宣布其經皮導管系統 UltraNav 已獲得美國食品和藥物管理局的批准。它通過經皮穿刺提供心血管導管的受控輸送。

主要關鍵參與者正在生產新穎和創新的產品，這些關鍵參與者正在進行各種管道和研究以推動市場增長。例如，2022 年 8 月，阿斯利康公佈了 DAPA-HF 和 DELIVER 的 3 期試驗分析的新結果，表明 Falixiga 與安慰劑相比在心力衰竭患者中的□□死亡率益處。

與診斷導管相關的副作用阻礙了市場增長。

然而，熟練醫務人員的短缺、嚴格的政府法規以及副作用的出現阻礙了市場的發展。其中，副作用的發生有望抑制市場。例如，中風、化學過敏和食道損傷在普通人群中很少見。

COVID-19 影響分析

與 Covid-19 傳播相關的封鎖和旅行限制給新的診斷導管製造商帶來了問題。由於 COVID-19 感染的傳播對主要經濟體產生了重大影響，診斷性導管插入藥物的生產受到了很大影響。

市場參與者正在改變他們的長期和短期增長戰略，利用研究市場和創造尖端產品來抗擊這一流行病。即使 COVID-19 對診斷導管行業造成影響，盡快制定業務運營的備用計劃也很重要。

您將可以訪問全球診斷導管市場報告中大約 40 多個市場數據表、45 多個數字和 200 頁（大約）。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 技術進步的增加
      • 增加創新產品的推出
    • 約束因素
      • 與診斷導管相關的副作用
      • 缺乏經驗豐富的專業人員
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按技術分類

  • 影像診斷
    • 血管造影導管
    • MRI 引導導管
    • 血管內超聲導管 (IVUS)
    • 電生理圖 (EP)
    • 心輸出量導管
  • 非影像診斷
    • 壓力監測導管
    • 流量監測導管
    • 血氧導管
    • 體溫監測導管
    • 重症監護監控系統

第 8 章按產品類型

  • 固定曲線導管
  • 導嚮導管
  • 高級映射導管

第 9 章。按應用程序

  • 循環區
  • 腸胃科
  • 泌尿科
  • 神經科

第 10 章，最終用戶

  • 醫院
  • 診斷中心
  • 專科診所
  • 其他

第 11 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 12 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 13 章公司簡介

  • B.Braun Melsungen AG
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Abbott
  • Medtronic
  • Boston Scientific
  • Infiniti Medical
  • Merit Medical
  • Osypka AG
  • Terumo Corporation
  • Johnson & Johnson
  • Royal Philips

第 14 章全球診斷導管市場-DataM

簡介目錄
Product Code: DMCD873

Market Overview

Diagnostic Catheter Market was valued at US$ 4,292.31 million in 2021 and is estimated to reach US$ 6,628.54 million by 2029, growing at a CAGR of 7.04% during the forecast period (2022-2029).

A diagnostic catheter is a thin plastic tube inserted into the artery through a small incision on the skin. Once the catheter is guided to the area to be examined, a contrast material (radiopaque media or therapeutic agent) is injected through the tube and images or required information are captured using technological equipment such as (micro cameras, x-ray fluids, pressure monitors, etc.).

Market Dynamics

The global diagnostic catheter market growth is driven by factors, such as the increase in cardiovascular surgeries globally, surgical procedures, and an inclination towards minimally invasive surgeries.

The increasing number of novel, innovative technological advancements are driving the market growth.

The market is driven by the increasing technological advancements related to diagnostic catheters fuelling the market's growth globally. For instance, in Jun 2021, Abbott announced that the company could support the growing demand for mechanical circulatory support devices to treat advanced heart failure properly.

According to the National Health and Nutrition Examination Survey (NHANES) data (2020), an estimated 6.2 million American adults ≥20 years of age (2.2%) had heart failure. More than 5.7 million Americans suffer from heart failure, and approximately 915,000 new patients are diagnosed annually. The prevalence of chronic ailments like heart failure, cardiovascular disease, and coronary artery disease is increasing due to unhealthy lifestyles and changing environments worldwide. These latest product launches and technological advances will be able to combat these diseases. For instance, In Apr 2022, Franklin Medical Mountain announced it received approval for UltraNav, a transseptal catheter system, from the United States Food and Drug Administration. It will provide controlled delivery of cardiovascular catheters by the transseptal puncture.

Major key players are producing novel, innovative products and various pipelines and studies are being conducted by these key players to derive market growth. For instance, in Aug 2022, AstraZeneca presented its novel results from the analysis of phase III trials of DAPA-HF and DELIVER that shows the mortality benefit of Farxiga over placebo in heart failure patients.

The side effects associated with diagnostic catheters will hamper the market's growth.

However, the lack of skilled medical professionals, stringent government regulations, and the onset of side effects hamper the market. Among these, the onset of side effects is expected to restrain the market. For instance, stroke, chemical allergies, and esophageal injury are seen in less percentage of the total population.

COVID-19 Impact Analysis

Due to lockdowns and travel restrictions brought on by the spread of COVID-19, makers of novel diagnostic catheters experienced problems. Because the spread of COVID-19 infections badly impacted major economies, diagnostic catheter therapeutics production was greatly impacted.

Market participants are changing their long-term and short-term growth strategies by utilizing the research market and creating cutting-edge items to combat the pandemic. Even though COVID-19 harmed the diagnostic catheter industry, preparing and implementing backup plans as soon as possible for business operations is crucial.

Segment Analysis

The imaging diagnostic catheters segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The imaging diagnostic has the largest market share in the forecast period. Electrophysiology mapping (EP) devices sub segment hold the largest market share as these catheter devices are often used to confirm the atrial fibrillation diagnosis and to decide its most suitable treatment. Due to its incorporated mapping capability, the usage of EP mapping catheters is increasing. The non-mapping electrophysiology catheters are less expensive than mapping ones as they do not provide the mapping. Various latest innovations are leading towards the growth of the market. For instance, in Jan 2022, Abbott announced that its cardiac mapping platform, Ensite X EP system with Omnipolar technology, got clearance from the U.S. FDA. This mapping system is developed to assist physicians in better treatment of cardiac arrhythmias. It provides the heart's detailed three-dimensional map as it's designed with the electrophysiologist's inputs.

Geographical Analysis

The North American region holds the largest global diagnostic catheter market.

North America dominates the diagnostic catheter market and is expected to show a similar trend over the forecast period. The growth of North American diagnostic catheters can be attributed to the rising prevalence of heart failure cases and the surge in the geriatric population. Strong healthcare infrastructure and an increase in research and development expenditure are to blame for this supremacy. Furthermore, the rising prevalence of cardiovascular diseases in this region due to unhealthy lifestyles and diets has propelled diagnostic catheter demand in the market.

According to the American Heart Association report 2020, approximately 790,000 people in the U.S. have heart attacks yearly. The rising number of people suffering from cardiovascular diseases and growing technological advancements and mergers or acquisitions by key players boost the demand for diagnostic catheter treatment in this region. For instance, in Jun 2021, Abiomed announced its acquisition of a precardiac catheter developer that provides less invasive options for treating patients with acute decompensated heart failure.

Competitive Landscape

The diagnostic catheter market is highly competitive with local and global companies. Some key players contributing to the market's growth are B. Braun Melsungen AG, Abbott, Medtronic, Boston Scientific, Infiniti Medical, Merit Medical, Osypka AG, Terumo Corporation, and Royal Philips, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the diagnostic catheter market globally. For instance, in Feb 2022, Interrad Medical, a private company of medical devices, and Eloquest Healthcare announced their strategic partnership to expand SecurAcath sales in the U.S.

B. Braun Melsungen AG.

Overview:

B. Braun is a company that manufactures medical and pharmaceuticals device. Headquartered in Melsungen, Germany and established in 1839. They provide services in around 60 countries and employ around 63,000 people. They have around 5,000 varieties of healthcare products.

Product Portfolio:

Angiodyn diagnostic catheters: Angiodyn diagnostic catheters are used for coronary angiographies. For 1:1 force transmission, it contains a symmetrical braided shaft.

Key Development:

In Jul 2022, B. Braun Medical Inc., a developer of infusion therapy, launched its one-time blood control Introcan safety 2 IV catheter. It is developed for safe IV access.

The global diagnostic catheter market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing novel technological advancements
      • 4.1.1.2. Growing innovative product launches
    • 4.1.2. Restraints:
      • 4.1.2.1. The side effects associated with these diagnostic catheters
      • 4.1.2.2. Unavailability of experienced professional
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Imaging *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Angiography catheters
    • 7.2.4. MRI-guided catheters
    • 7.2.5. Intravascular ultrasonic catheters (IVUS)
    • 7.2.6. Electrophysiology mapping (EP)
    • 7.2.7. Cardiac output catheters
  • 7.3. Non-Imaging
    • 7.3.1. Pressure monitoring catheters
    • 7.3.2. Flow monitoring catheters
    • 7.3.3. Oximetry catheters
    • 7.3.4. Temperature monitoring catheters
    • 7.3.5. Critical care monitoring systems

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Fixed curve Catheters *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Steerable Catheters
  • 8.4. Advanced mapping Catheters

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Cardiology*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Gastroenterology
  • 9.4. Urology
  • 9.5. Neurology

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospital*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Diagnostic Centers
  • 10.4. Specialty Clinics
  • 10.5. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. B.Braun Melsungen AG*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Abbott
  • 13.3. Medtronic
  • 13.4. Boston Scientific
  • 13.5. Infiniti Medical
  • 13.6. Merit Medical
  • 13.7. Osypka AG
  • 13.8. Terumo Corporation
  • 13.9. Johnson & Johnson
  • 13.10. Royal Philips

LIST NOT EXHAUSTIVE

14. Global Diagnostic Catheter Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us